Back to Search
ROBERTO CIVITELLI, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1194743872IndividualAccepts Medicare
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
36936(MO)
Education
OTHER
Class of 1980
Research & Publications (20)
Bone turnover markers: understanding their value in clinical trials and clinical practice.
PMID 19190842·Osteoporos Int·2009
6-review
Cell-cell communication in the osteoblast/osteocyte lineage.
PMID 18424255·Arch Biochem Biophys·2008
6-review
Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: a randomized, double-blind, placebo-controlled trial.
PMID 12076241·Arch Intern Med·2002
3-trial
Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronate.
PMID 19563245·J Womens Health (Larchmt)·2009
4-observational
Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series.
PMID 19548019·Calcif Tissue Int·2009
5-case
Calcium and vitamin D use among adults in periodontal disease maintenance programmes.
PMID 19557061·Br Dent J·2009
4-observational
Connexin43 modulation of osteoblast/osteocyte apoptosis: a potential therapeutic target?
PMID 18925861·J Bone Miner Res·2008
7-preclinical
The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans.
PMID 18003637·Hum Mol Genet·2008
7-preclinical
The pro-osteogenic action of beta-catenin requires interaction with BMP signaling, but not Tcf/Lef transcriptional activity.
PMID 18247340·J Cell Biochem·2008
7-preclinical
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
PMID 18260172·J Rheumatol·2008
4-observational
Attenuated response to in vivo mechanical loading in mice with conditional osteoblast ablation of the connexin43 gene (Gja1).
PMID 18282131·J Bone Miner Res·2008
7-preclinical
Safety considerations with bisphosphonates for the treatment of osteoporosis.
PMID 17722968·Drug Saf·2007
6-review
Maintaining the trust of physicians and the public in the medical literature: report of a task force on scientific publishing of clinical trials.
PMID 17907954·J Bone Miner Res·2007
8-other
Effects of dietary calcium compared with calcium supplements on estrogen metabolism and bone mineral density.
PMID 17490982·Am J Clin Nutr·2007
8-other
Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment.
PMID 17558311·Pharmacogenet Genomics·2007
8-other
Bone loss after temporarily induced muscle paralysis by Botox is not fully recovered after 12 weeks.
PMID 17584988·Ann N Y Acad Sci·2007
7-preclinical
Cell-cell adhesion and signaling through cadherins: connecting bone cells in their microenvironment.
PMID 17002562·J Bone Miner Res·2006
6-review
Accentuated ovariectomy-induced bone loss and altered osteogenesis in heterozygous N-cadherin null mice.
PMID 17002573·J Bone Miner Res·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10 BARNES WEST DR, DIV IM BONE AND MINERAL, STE 200
SAINT LOUIS, MO 63141 - Phone
- (314) 454-7775
Quick Facts
- NPI
- 1194743872
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile